European Commission Directorate General for Research and Innovation opens public consultation on Horizon 2020

European commission header

On the 20th of October, the European Commission DG Research & Innovation opened a public consultation on the EU funding programme for research and innovation Horizon 2020. The consultation is open until the 15th of January 2017 and provides an opportunity for all interested parties to give their views on the programme and suggestions for the future, in order to contribute to improving its overall functioning.

Horizon 2020, the multiannual funding scheme of the European Commission to fund research and innovation projects started in 2014 and runs to 2020 with a budget of €77 billion.

Of note, by September 1, 2016, over 9000 grant agreements were signed following calls with deadlines in 2014 and 2015, for a total of €16 billion.

Contributions to this consultation are particularly sought from researchers, entrepreneurs, innovators and all types of organisations that have participated in Horizon 2020.

The input provided through this public stakeholder consultation will be reflected in the interim evaluation of the H2020 scheme to be delivered by the European Commission by the 31st of December 2017. This evaluation will consist of three deliverables:

  • A Staff Working Document which will present and summarise all the evidence gathered, factual evaluation results and lessons learnt for the future
  • A report from a High Level Group with strategic conclusions on further boosting the impact of EU research and innovation funding, and a vision for future EU research and innovation
  • A Communication from the Commission on the key evaluation results, observations on the report of the High Level Group, and implementation of the recommendations of the ex-post evaluation of FP7, the predecessor of Horizon 2020

You can preview the questionnaire here for your info and access the link to answer to it here.

Please also note that a specific consultation on public-public and public-private partnerships under Horizon 2020 will also be launched in the coming months.
Last updated 28 November 2016
EAACI's EU liaison office in Brussels acts as the contact point for internal and external EAACI EU Affairs relations.
EAACI – EU Liaison Office
Rue du Luxembourg, 22-24
B-1000 Brussels
Tel : +32 (2)2 761 66 83


As the leading European medical society focusing on allergy, EAACI has a key role to play in the formulation of health and research policies at the European level. EAACI activities focus on improving allergy care, fostering allergy research and help strengthen Allergology as a medical specialty.

By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback